CRISPR Gene Editing in Stem Cells
|
SnapShots |
9 |
|
Class 1 CRISPR-Cas Systems |
9 |
|
Class 2 CRISPR-Cas Systems |
11 |
|
Reviews |
13 |
|
Induced Pluripotent Stem Cells Meet Genome Editing |
13 |
|
Applications of CRISPR Genome Engineering in Cell Biology |
27 |
|
Articles |
41 |
|
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells |
41 |
|
CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs |
49 |
|
Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells |
62 |
|
Interspecies Chimerism with Mammalian Pluripotent Stem Cells |
71 |
|
A G-Rich Motif in the lncRNA Braveheart Interacts with a Zinc-Finger Transcription Factor to Specify the Cardiovascular Lineage |
85 |
|
An Isogenic Human ESC Platform for Functional Evaluation of Genome-wide-Association-Study-Identified Diabetes Genes and Drug Discovery |
100 |
|
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia |
115 |